Pre-order Enquiry
Request Free Sample
Global Ganirelix Market Research Report 2020
SKU ID : QYR-15513396 | Publishing Date : 02-Apr-2020 | No. of pages : 96
Detailed TOC of Global Ganirelix Market Research Report 2020
1 Ganirelix Market Overview1.1 Product Overview and Scope of Ganirelix
1.2 Ganirelix Segment by Type
1.2.1 Global Ganirelix Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Patent
1.2.3 Generic
1.3 Ganirelix Segment by Application
1.3.1 Ganirelix Sales Comparison by Application: 2020 VS 2026
1.3.2 Polycystic Ovaries Syndrome
1.3.3 Ovarian Stimulation
1.3.4 Orthostatic Intolerance
1.3.5 Controlled Ovarian Stimulation
1.3.6 Infertility
1.4 Global Ganirelix Market Size Estimates and Forecasts
1.4.1 Global Ganirelix Revenue 2015-2026
1.4.2 Global Ganirelix Sales 2015-2026
1.4.3 Ganirelix Market Size by Region: 2020 Versus 2026
2 Global Ganirelix Market Competition by Manufacturers
2.1 Global Ganirelix Sales Market Share by Manufacturers (2015-2020)
2.2 Global Ganirelix Revenue Share by Manufacturers (2015-2020)
2.3 Global Ganirelix Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Ganirelix Manufacturing Sites, Area Served, Product Type
2.5 Ganirelix Market Competitive Situation and Trends
2.5.1 Ganirelix Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Ganirelix Players (Opinion Leaders)
3 Ganirelix Retrospective Market Scenario by Region
3.1 Global Ganirelix Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Ganirelix Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Ganirelix Market Facts & Figures by Country
3.3.1 North America Ganirelix Sales by Country
3.3.2 North America Ganirelix Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Ganirelix Market Facts & Figures by Country
3.4.1 Europe Ganirelix Sales by Country
3.4.2 Europe Ganirelix Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Ganirelix Market Facts & Figures by Region
3.5.1 Asia Pacific Ganirelix Sales by Region
3.5.2 Asia Pacific Ganirelix Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Ganirelix Market Facts & Figures by Country
3.6.1 Latin America Ganirelix Sales by Country
3.6.2 Latin America Ganirelix Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Ganirelix Market Facts & Figures by Country
3.7.1 Middle East and Africa Ganirelix Sales by Country
3.7.2 Middle East and Africa Ganirelix Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Ganirelix Historic Market Analysis by Type
4.1 Global Ganirelix Sales Market Share by Type (2015-2020)
4.2 Global Ganirelix Revenue Market Share by Type (2015-2020)
4.3 Global Ganirelix Price Market Share by Type (2015-2020)
4.4 Global Ganirelix Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Ganirelix Historic Market Analysis by Application
5.1 Global Ganirelix Sales Market Share by Application (2015-2020)
5.2 Global Ganirelix Revenue Market Share by Application (2015-2020)
5.3 Global Ganirelix Price by Application (2015-2020)
6 Company Profiles and Key Figures in Ganirelix Business
6.1 Organon
6.1.1 Corporation Information
6.1.2 Organon Description, Business Overview and Total Revenue
6.1.3 Organon Ganirelix Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Organon Products Offered
6.1.5 Organon Recent Development
6.2 Sun Pharm
6.2.1 Sun Pharm Ganirelix Production Sites and Area Served
6.2.2 Sun Pharm Description, Business Overview and Total Revenue
6.2.3 Sun Pharm Ganirelix Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Sun Pharm Products Offered
6.2.5 Sun Pharm Recent Development
6.3 Merck Sharp and Dohme (MSD)
6.3.1 Merck Sharp and Dohme (MSD) Ganirelix Production Sites and Area Served
6.3.2 Merck Sharp and Dohme (MSD) Description, Business Overview and Total Revenue
6.3.3 Merck Sharp and Dohme (MSD) Ganirelix Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Merck Sharp and Dohme (MSD) Products Offered
6.3.5 Merck Sharp and Dohme (MSD) Recent Development
6.4 Ferring Pharmaceuticals
6.4.1 Ferring Pharmaceuticals Ganirelix Production Sites and Area Served
6.4.2 Ferring Pharmaceuticals Description, Business Overview and Total Revenue
6.4.3 Ferring Pharmaceuticals Ganirelix Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Ferring Pharmaceuticals Products Offered
6.4.5 Ferring Pharmaceuticals Recent Development
6.5 Ambinter
6.5.1 Ambinter Ganirelix Production Sites and Area Served
6.5.2 Ambinter Description, Business Overview and Total Revenue
6.5.3 Ambinter Ganirelix Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Ambinter Products Offered
6.5.5 Ambinter Recent Development
6.6 BLD Pharm
6.6.1 BLD Pharm Ganirelix Production Sites and Area Served
6.6.2 BLD Pharm Description, Business Overview and Total Revenue
6.6.3 BLD Pharm Ganirelix Sales, Revenue and Gross Margin (2015-2020)
6.6.4 BLD Pharm Products Offered
6.6.5 BLD Pharm Recent Development
6.7 Chemenu
6.6.1 Chemenu Ganirelix Production Sites and Area Served
6.6.2 Chemenu Description, Business Overview and Total Revenue
6.6.3 Chemenu Ganirelix Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Chemenu Products Offered
6.7.5 Chemenu Recent Development
7 Ganirelix Manufacturing Cost Analysis
7.1 Ganirelix Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Ganirelix
7.4 Ganirelix Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Ganirelix Distributors List
8.3 Ganirelix Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Ganirelix Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Ganirelix by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Ganirelix by Type (2021-2026)
10.2 Ganirelix Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Ganirelix by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Ganirelix by Application (2021-2026)
10.3 Ganirelix Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Ganirelix by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Ganirelix by Region (2021-2026)
10.4 North America Ganirelix Estimates and Projections (2021-2026)
10.5 Europe Ganirelix Estimates and Projections (2021-2026)
10.6 Asia Pacific Ganirelix Estimates and Projections (2021-2026)
10.7 Latin America Ganirelix Estimates and Projections (2021-2026)
10.8 Middle East and Africa Ganirelix Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Ganirelix Market Research Report 2020
List of TablesTable 1. Global Ganirelix Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Ganirelix Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Ganirelix Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Ganirelix Manufacturers Covered in This Study
Table 5. Global Ganirelix Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Ganirelix Sales Share by Manufacturers (2015-2020)
Table 7. Global Ganirelix Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Ganirelix Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Ganirelix Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Ganirelix Sales Sites and Area Served
Table 11. Manufacturers Ganirelix Product Types
Table 12. Global Ganirelix Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Ganirelix by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ganirelix as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Ganirelix Players
Table 16. Global Ganirelix Sales (K Units) by Region (2015-2020)
Table 17. Global Ganirelix Sales Market Share by Region (2015-2020)
Table 18. Global Ganirelix Revenue (Million US$) by Region (2015-2020)
Table 19. Global Ganirelix Revenue Market Share by Region (2015-2020)
Table 20. North America Ganirelix Sales by Country (2015-2020) (K Units)
Table 21. North America Ganirelix Sales Market Share by Country (2015-2020)
Table 22. North America Ganirelix Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Ganirelix Revenue Market Share by Country (2015-2020)
Table 24. Europe Ganirelix Sales by Country (2015-2020) (K Units)
Table 25. Europe Ganirelix Sales Market Share by Country (2015-2020)
Table 26. Europe Ganirelix Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Ganirelix Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Ganirelix Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Ganirelix Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Ganirelix Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Ganirelix Revenue Market Share by Region (2015-2020)
Table 32. Latin America Ganirelix Sales by Country (2015-2020) (K Units)
Table 33. Latin America Ganirelix Sales Market Share by Country (2015-2020)
Table 34. Latin America Ganirelix Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Ganirelix Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Ganirelix Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Ganirelix Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Ganirelix Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Ganirelix Revenue Market Share by Country (2015-2020)
Table 40. Global Ganirelix Sales (K Units) by Type (2015-2020)
Table 41. Global Ganirelix Sales Share by Type (2015-2020)
Table 42. Global Ganirelix Revenue (Million US$) by Type (2015-2020)
Table 43. Global Ganirelix Revenue Share by Type (2015-2020)
Table 44. Global Ganirelix Price (US$/Unit) by Type (2015-2020)
Table 45. Global Ganirelix Sales (K Units) by Application (2015-2020)
Table 46. Global Ganirelix Sales Market Share by Application (2015-2020)
Table 47. Global Ganirelix Sales Growth Rate by Application (2015-2020)
Table 48. Organon Ganirelix Corporation Information
Table 49. Organon Description and Business Overview
Table 50. Organon Ganirelix Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 51. Organon Main Product
Table 52. Organon Recent Development
Table 53. Sun Pharm Ganirelix Corporation Information
Table 54. Sun Pharm Corporation Information
Table 55. Sun Pharm Ganirelix Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Sun Pharm Main Product
Table 57. Sun Pharm Recent Development
Table 58. Merck Sharp and Dohme (MSD) Ganirelix Corporation Information
Table 59. Merck Sharp and Dohme (MSD) Corporation Information
Table 60. Merck Sharp and Dohme (MSD) Ganirelix Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Merck Sharp and Dohme (MSD) Main Product
Table 62. Merck Sharp and Dohme (MSD) Recent Development
Table 63. Ferring Pharmaceuticals Ganirelix Corporation Information
Table 64. Ferring Pharmaceuticals Corporation Information
Table 65. Ferring Pharmaceuticals Ganirelix Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Ferring Pharmaceuticals Main Product
Table 67. Ferring Pharmaceuticals Recent Development
Table 68. Ambinter Ganirelix Corporation Information
Table 69. Ambinter Corporation Information
Table 70. Ambinter Ganirelix Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Ambinter Main Product
Table 72. Ambinter Recent Development
Table 73. BLD Pharm Ganirelix Corporation Information
Table 74. BLD Pharm Corporation Information
Table 75. BLD Pharm Ganirelix Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. BLD Pharm Main Product
Table 77. BLD Pharm Recent Development
Table 78. Chemenu Ganirelix Corporation Information
Table 79. Chemenu Corporation Information
Table 80. Chemenu Ganirelix Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Chemenu Main Product
Table 82. Chemenu Recent Development
Table 83. Sales Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Ganirelix Distributors List
Table 86. Ganirelix Customers List
Table 87. Market Key Trends
Table 88. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 89. Key Challenges
Table 90. Global Ganirelix Sales (K Units) Forecast by Type (2021-2026)
Table 91. Global Ganirelix Sales Market Share Forecast by Type (2021-2026)
Table 92. Global Ganirelix Revenue (Million US$) Forecast by Type (2021-2026)
Table 93. Global Ganirelix Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 94. Global Ganirelix Sales (K Units) Forecast by Application (2021-2026)
Table 95. Global Ganirelix Revenue (Million US$) Forecast by Application (2021-2026)
Table 96. Global Ganirelix Sales (K Units) Forecast by Region (2021-2026)
Table 97. Global Ganirelix Sales Market Share Forecast by Region (2021-2026)
Table 98. Global Ganirelix Revenue Forecast by Region (2021-2026) (US$ Million)
Table 99. Global Ganirelix Revenue Market Share Forecast by Region (2021-2026)
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Ganirelix
Figure 2. Global Ganirelix Sales Market Share by Type: 2020 VS 2026
Figure 3. Patent Product Picture
Figure 4. Generic Product Picture
Figure 5. Global Ganirelix Consumption Market Share by Application: 2020 VS 2026
Figure 6. Polycystic Ovaries Syndrome
Figure 7. Ovarian Stimulation
Figure 8. Orthostatic Intolerance
Figure 9. Controlled Ovarian Stimulation
Figure 10. Infertility
Figure 11. Global Ganirelix Market Size 2015-2026 (US$ Million)
Figure 12. Global Ganirelix Sales Capacity (K Units) (2015-2026)
Figure 13. Global Ganirelix Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Ganirelix Sales Share by Manufacturers in 2020
Figure 15. Global Ganirelix Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Ganirelix Revenue in 2019
Figure 17. Ganirelix Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Ganirelix Sales Market Share by Region (2015-2020)
Figure 19. Global Ganirelix Sales Market Share by Region in 2019
Figure 20. Global Ganirelix Revenue Market Share by Region (2015-2020)
Figure 21. Global Ganirelix Revenue Market Share by Region in 2019
Figure 22. North America Ganirelix Sales Market Share by Country in 2019
Figure 23. North America Ganirelix Revenue Market Share by Country in 2019
Figure 24. U.S. Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 25. U.S. Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 27. Canada Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Ganirelix Sales Market Share by Country in 2019
Figure 29. Europe Ganirelix Revenue Market Share by Country in 2019
Figure 30. Germany Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 31. Germany Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 33. France Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.K. Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 37. Italy Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 39. Russia Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Ganirelix Sales Market Share by Region in 2019
Figure 41. Asia Pacific Ganirelix Revenue Market Share by Region in 2019
Figure 42. China Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 43. China Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 45. Japan Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 47. South Korea Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 49. India Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 51. Australia Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 53. Taiwan Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 55. Indonesia Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 57. Thailand Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 59. Malaysia Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 61. Philippines Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 63. Vietnam Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Ganirelix Sales Market Share by Country in 2019
Figure 65. Latin America Ganirelix Revenue Market Share by Country in 2019
Figure 66. Mexico Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 67. Mexico Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 69. Brazil Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Ganirelix Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Ganirelix Revenue Market Share by Country in 2019
Figure 74. Turkey Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 75. Turkey Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 77. Saudi Arabia Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E Ganirelix Sales Growth Rate (2015-2020) (K Units)
Figure 79. U.A.E Ganirelix Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Ganirelix by Type (2015-2020)
Figure 81. Sales Market Share of Ganirelix by Type in 2019
Figure 82. Revenue Share of Ganirelix by Type (2015-2020)
Figure 83. Revenue Market Share of Ganirelix by Type in 2019
Figure 84. Global Ganirelix Sales Growth by Type (2015-2020) (K Units)
Figure 85. Global Ganirelix Sales Market Share by Application (2015-2020)
Figure 86. Global Ganirelix Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Ganirelix by Application (2015-2020)
Figure 88. Global Revenue Share of Ganirelix by Application in 2020
Figure 89. Organon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Sun Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Merck Sharp and Dohme (MSD) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Ferring Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Ambinter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. BLD Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Chemenu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Price Trend of Key Raw Materials
Figure 97. Manufacturing Cost Structure of Ganirelix
Figure 98. Manufacturing Process Analysis of Ganirelix
Figure 99. Ganirelix Industrial Chain Analysis
Figure 100. Channels of Distribution
Figure 101. Distributors Profiles
Figure 102. Porter's Five Forces Analysis
Figure 103. North America Ganirelix Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 104. North America Ganirelix Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 105. Europe Ganirelix Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 106. Europe Ganirelix Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Latin America Ganirelix Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. Latin America Ganirelix Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Middle East and Africa Ganirelix Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Middle East and Africa Ganirelix Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Asia Pacific Ganirelix Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. Asia Pacific Ganirelix Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed
Keyplayers in Global Ganirelix Market Research Report 2020
OrganonSun Pharm
Merck Sharp and Dohme (MSD)
Ferring Pharmaceuticals
Ambinter
BLD Pharm
Chemenu
Request Sample
Request Discount
